Anthera Featured by Kathimerini: A New Chapter for Greek Medical Cannabis
Anthera Featured by Kathimerini: A New Chapter for Greek Medical Cannabis
Anthera Pharmaceuticals has been featured by Kathimerini, one of Greece’s leading newspapers, in an article highlighting the company’s journey and its contribution to the development of the country’s pharmaceutical cannabis industry.
The feature presents Anthera as a vertically integrated Greek pharmaceutical company that combines controlled cultivation, pharmaceutical manufacturing, quality control, and quality assurance under one operation in Ancient Corinth. It also outlines the company’s recent licensing milestone, its investment in pharmaceutical infrastructure, and its commitment to producing medical cannabis according to GACP and EU-GMP standards.
The article also discusses Anthera’s long-term vision of delivering consistent, pharmaceutical-grade medical cannabis products to patients in Greece and international markets while investing in scientific expertise, quality systems, and continuous innovation.
We are honored by this recognition and grateful to Kathimerini for showcasing the work of our team and the growing role of Greece in the European medical cannabis industry.
Read the full article:
